Cargando…
Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations
Mycobacterium are among the oldest co-evolutionary partners of humans. The attenuated Mycobacterium bovis Bacillus Calmette Guérin (BCG) strain has been administered globally for 100 years as a vaccine against tuberculosis. BCG also shows promise as treatment for numerous inflammatory and autoimmune...
Autores principales: | Kühtreiber, Willem M., Tran, Lisa, Kim, Taesoo, Dybala, Michael, Nguyen, Brian, Plager, Sara, Huang, Daniel, Janes, Sophie, Defusco, Audrey, Baum, Danielle, Zheng, Hui, Faustman, Denise L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013479/ https://www.ncbi.nlm.nih.gov/pubmed/29951281 http://dx.doi.org/10.1038/s41541-018-0062-8 |
Ejemplares similares
-
MON-179 Repeat BCG Vaccination Creates Lasting HbA1c Reductions in Adult Subjects with Longstanding Type 1 Diabetes by Correcting Immune-Metabolic Defects
por: Faustman, Denise, et al.
Publicado: (2019) -
THU266 Lowered HbA1c In Individuals With Long-term Type 1 Diabetes Undergoing BCG Bladder Cancer Therapy
por: Dias, Hans, et al.
Publicado: (2023) -
BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation
por: Keefe, Ryan C., et al.
Publicado: (2021) -
Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies
por: Dias, Hans F., et al.
Publicado: (2023) -
THU284 BCG Clinical Trial Programs In Advanced Type 1 Diabetes - 2023 Update
por: Kühtreiber, Willem M, et al.
Publicado: (2023)